Wilson's disease: Clinical, genetic and pharmacological findings

International Journal of Immunopathology and Pharmacology

Volumn 18, Issue 1, 2005, Pages 7-14

  Leggio, L ^a   Addolorato, Giovanni ^a   Abenavoli, L ^a   Gasbarrini, G ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Copper accumulation; Drug therapy; Wilson's disease

Indexed keywords

CERULOPLASMIN; CHELATING AGENT; COPPER; DIMERCAPROL; PENICILLAMINE; TETRATHIOMOLYBDIC ACID; TRIENTINE; ZINC ACETATE;

AUTOSOMAL RECESSIVE DISORDER; BONE MARROW SUPPRESSION; CHELATION; CLINICAL FEATURE; COPPER BLOOD LEVEL; COPPER METABOLISM; CUTIS LAXA; DIAGNOSTIC IMAGING; DIET THERAPY; DRUG APPROVAL; DRUG SAFETY; ELASTOSIS; FEVER; GENE MUTATION; GOODPASTURE SYNDROME; HISTOLOGY; HUMAN; HYPERTENSION; IMMUNE COMPLEX NEPHRITIS; LABORATORY TEST; LIVER BIOPSY; LIVER DISEASE; LIVER FAILURE; LIVER TOXICITY; LIVER TRANSPLANTATION; MOUTH ULCER; MYASTHENIA GRAVIS; NAUSEA; NEUROLOGICAL COMPLICATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE DISEASE; PEMPHIGUS; PHENOTYPE; PRIORITY JOURNAL; PYRIDOXINE DEFICIENCY; REVIEW; SIDEROBLASTIC ANEMIA; SYSTEMIC LUPUS ERYTHEMATOSUS; TACHYCARDIA; VOMITING; WILSON DISEASE;

EID: 14844288014     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200501800102     Document Type: Review

References (38)

1. Wilson S.A.K. 1912. Progressive lenticular degeneration: a familiar nervous disease associated with cirrhosis of the liver. Lancet 1:1115.
2. Gitlin, J.D. 2003. Wilson disease. Gastroenterology 125:1868.
3. Loudianos G. and J.D. Gitlin. 2000. Wilson's disease. Semin. Liver Dis. 20:353.
4. Ferenci P. 2002. Genotype-phenotype correlations in Wilson disease. J. Hepatol. 36(S):158.
5. Loudianos G., V. Dessi, M. Lovicu, A. Angius, A. Figus, F. Lilliu, S. De Virgiliis, A.M. Nurchi, A. Deplano, P. Moi, M. Pirastu and A. Cao. 1999. Molecular characterization of Wilson disease in the Sardinian population - evidence of a founder effect. Hum. Mutat. 14:294.
6. Chuang L.M., H.P. Wu, M.H. Jang, T.R. Wang, W.C. Sue, B.J. Lin, D.W. Cox and T.Y. Tai. 1996. High frequency of two mutations in codon 778 in exon 8 of the ATP7B gene in Taiwanese families with Wilson disease. J. Med. Genet. 33:521.
7. Loudianos G., V. Kostic, P. Solinas, M. Lovicu, V. Dessi, M. Svetel, T. Major and A. Cao. 2003. Characterization of the molecular defect in the ATP7B gene in Wilson disease patients from Yugoslavia. Genet. Test 7:107.
8. Ferenci P. 2004. Review article: diagnosis and current therapy of Wilson's disease. Aliment. Pharmacol. Ther. 19:157.
9. Schilsky M.L. 2002. Diagnosis and treatment of Wilson's disease. Pediatr. Transplantation 6:15.
10. Shim H. and Z.L. Harris. 2003. Genetic defects in copper metabolism. J. Nutr. 133:527.
11. Zhou B. and J. Gitschier. 1997. hCTR1: a human gene for copper uptake identified by complementation in yeast. Proc. Natl. Acad. Sci. USA 94:7481.
12. Leung T.K., L. Lim and J.C. Lai. 1992. Differential effects of metal ions on type A and type B monoamine oxidase activities in rat brain and liver mitochondria. Metab. Brain. Dis. 7:139.
13. Ferenci P., K. Caca, G. Loudianos, G. Mieli-Vergani, S. Tanner, I. Sternlieb, M. Schilsky, D. Cox and F. Berr. 2003. Diagnosis and phenotypic classification of Wilson disease. Liver Int. 23:139.
14. Huang C.C., N.S. Chu, T.C. Yen, Y.Y. Wai and C.S. Lu. 2003. Dopamine transporter binding in Wilson's disease. Can. J. Neurol. Sci. 30:163.
15. Dening T.R. 1991. The neuropsychiatry of Wilson's disease: a review. Int. J. Psychiatry Med. 21:135.
16. Akil M. and G.J. Brewer. 1995. Psychiatric and behavioral abnormalities in Wilson's disease. Adv. Neurol. 65:171.
17. Hesse S., H. Barthel, W. Hermann, T. Murai, R. Kluge, A. Wagner, O. Sabri and B. Eggers. 2003. Regional serotonin transporter availability and depression are correlated in Wilson's disease. J. Neurol. Transm. 110:923.
18. Ferraro L., K. Fuxe, S. Tanganelli, M.C. Tomasini, F.A. Lambert and T. Antonelli. 2002. Differential enhancement of dialysate serotonin levels in distinct brain regions of the awake rat by modafinil: possible relevance for wakefulness and depression. J. Neurosci. Res. 68:107.
19. Stremmel W., K.W. Meyerrose, C. Niederau, H. Hefter, G. Kreuzpaintner and G. Strohmeyer. 1991. Wilson disease: clinical presentation, treatment, and survival. Ann. Intern. Med. 115:720.
20. Sinha S., A.B. Taly, L.K. Prashanth, G.R. Arunodaya and H.S. Swamy. 2004. Successful pregnancies and abortions in symptomatic and asymptomatic Wilson's disease. J. Neurol. Sci. 217:37.
21. Gasbarrini G., G.R. Corazza and F. Bonvicini. 1979. Lysosomal changes and enterocytic copper deposits in Wilson's disease. Digestion 19:346.
22. Sagawa M., M. Takao, S. Nogawa, M. Mizuno, M. Murata, T. Amano and A. Koto. 2003. Wilson's disease associated with olfactory paranoid syndrome and idiopathic thrombocytopenic purpura. No. To. Shinkei 55:899.
23. Polio J., R.E. Enriquez, A. Chow, W.M. Wood and C.E. Atterbury. 1989. Hepatocellular carcinoma in Wilson's disease. Case report and review of literature. J. Clin. Gastroenterol. 11 220.
24. Walshe J.M., E. Waldenstrom, V. Sams, H. Nordlinder and K. Westermark. 2003. Abdominal malignancies in patients with Wilson's disease. Q.J.M. 96:657.
25. Milkiewicz P., S. Saksena, S.G. Hubscher and E. Elias. 2000. Wilson's disease with superimposed autoimmune features: report of two cases and review. J. Gastroenterol. Hepatol. 15:570.
26. Sternlieb I. 1990. Perspective on Wilson's disease. Hepatology 12:1234.
27. Walshe J.M. 1956. Penicillamine. A new oral therapy for Wilson's disease. Am. J. Med. 21:487.
28. Walshe J.M. 1982. Treatment of Wilson's disease with trientine(triethylenetetramine)dichloride. Lancet1:643.
29. th ed. Lange Medical Publications Los Altos, p. 1.
30. Brewer G.J. 2003. Tetrathiomolybdate anticopper therapy for Wilson's disease inhibits angiogenesis, fibrosis and inflammation. J. Cell. Mol. Med. 7:11.
31. Brewer G.J., R.D. Dick, V.D. Johnson, J.K. Fink, K.J. Kluin and S. Daniels. 2001. Treatment of Wilson's disease with zinc XVI: treatment during the pediatric years. J. Lab. Clin. Med. 137 191.
32. Guarino M., A. Stracciari, R. D'Alessandro and P. Pazzaglia. 1995. No neurological improvement after liver transplantation for Wilson's disease. Acta Neurol. Scand. 92:405.
33. Asonuma K., Y. Inomata, M. Kasahara, S. Uemoto, H. Egawa, S. Fujita, T. Kiuchi, M. Hayashi and K. Tanaka. 1999. Living related liver transplantation from heterozygote genetic carriers to children with Wilson's disease. Pediatr. Transplant. 3:201.
34. Schilsky M.L., I.H. Scheinberg and I. Sternlieb. 1994. Liver transplantation for Wilson's disease: indications and outcome. Hepatology 19:583.
35. Roberts E.A. and M.L. Schilsky. 2003. AASLD practice guidelines. A practice guidelines on Wilson's disease. Hepatology 37:1475.
36. Austen W.G. Jr., L. Kobzik, M.C. Carroll, H.B. Hechtman and F.D. Moore Jr. 2003. The role of complement and natural antibody in intestinal ischemia-reperfusion injury. Int. J. Immunopathol. Pharmacol. 16:1.
37. Bogdanos D. P., M. Lenzi, M. Okamoto, E.I. Rigopoulou, P. Muratori, Y. Ma, L. Muratori, D. Tsantoulas, G. Mieli-Vergani, F.B. Bianchi and D. Vergani. 2004. Multiple viral/self immunological cross-reactivity in liver kidney microsomal antibody positive hepatitis C virus infected patients is associated with the possession of HLA b51. Int. J. Immunopathol. Pharmacol. 17:83.
38. Kempuraj D., J. Donelan, S. Frydas, T. Iezzi, P. Conti, W. Boucher, N. G. Papadoopoulou, B. Madhappan, L. Letourneau, G. Sabatino, G. Riccioni and T.C. Theoharides. 2004. Interleukin-28 and 29 (IL-28 and IL-29): new cytokines with anti-viral activities. Int. J. Immunopathol. Pharmacol. 17:103.